GB201609722D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB201609722D0
GB201609722D0 GBGB1609722.2A GB201609722A GB201609722D0 GB 201609722 D0 GB201609722 D0 GB 201609722D0 GB 201609722 A GB201609722 A GB 201609722A GB 201609722 D0 GB201609722 D0 GB 201609722D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1609722.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coegin Pharma AS
Original Assignee
Avexxin AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avexxin AS filed Critical Avexxin AS
Priority to GBGB1609722.2A priority Critical patent/GB201609722D0/en
Publication of GB201609722D0 publication Critical patent/GB201609722D0/en
Priority to JP2018563499A priority patent/JP2019517527A/en
Priority to CN201780034460.8A priority patent/CN109310770A/en
Priority to US16/306,161 priority patent/US20200323793A1/en
Priority to AU2017272889A priority patent/AU2017272889B2/en
Priority to PCT/EP2017/063627 priority patent/WO2017207819A1/en
Priority to EP17729834.6A priority patent/EP3463475A1/en
Priority to KR1020187036652A priority patent/KR20190016036A/en
Priority to CA3025698A priority patent/CA3025698A1/en
Priority to IL263206A priority patent/IL263206A/en
Priority to AU2020202338A priority patent/AU2020202338A1/en
Ceased legal-status Critical Current

Links

GBGB1609722.2A 2016-06-03 2016-06-03 Combination therapy Ceased GB201609722D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB1609722.2A GB201609722D0 (en) 2016-06-03 2016-06-03 Combination therapy
CA3025698A CA3025698A1 (en) 2016-06-03 2017-06-05 Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor
AU2017272889A AU2017272889B2 (en) 2016-06-03 2017-06-05 Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor
CN201780034460.8A CN109310770A (en) 2016-06-03 2017-06-05 Conjoint therapy comprising how unsaturated ketone and calcineurin inhibitors
US16/306,161 US20200323793A1 (en) 2016-06-03 2017-06-05 Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor
JP2018563499A JP2019517527A (en) 2016-06-03 2017-06-05 Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor
PCT/EP2017/063627 WO2017207819A1 (en) 2016-06-03 2017-06-05 Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor
EP17729834.6A EP3463475A1 (en) 2016-06-03 2017-06-05 Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor
KR1020187036652A KR20190016036A (en) 2016-06-03 2017-06-05 Combination therapies including polyunsaturated ketones and calcineurin inhibitors
IL263206A IL263206A (en) 2016-06-03 2018-11-22 Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor
AU2020202338A AU2020202338A1 (en) 2016-06-03 2020-04-02 Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1609722.2A GB201609722D0 (en) 2016-06-03 2016-06-03 Combination therapy

Publications (1)

Publication Number Publication Date
GB201609722D0 true GB201609722D0 (en) 2016-07-20

Family

ID=56508020

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1609722.2A Ceased GB201609722D0 (en) 2016-06-03 2016-06-03 Combination therapy

Country Status (1)

Country Link
GB (1) GB201609722D0 (en)

Similar Documents

Publication Publication Date Title
IL263521A (en) Combination therapy
IL257976A (en) Combination therapy
GB201516442D0 (en) Combination therapy
IL265406B (en) Combination therapy
HK1255110A1 (en) Combination therapy
GB201609597D0 (en) Therapy
GB201604318D0 (en) Combination therapy
GB201604316D0 (en) Combination therapy
IL265340A (en) Combination therapy
GB201609735D0 (en) Combination therapy
GB201603653D0 (en) Combination Therapy
GB201618477D0 (en) Therapy
GB201613179D0 (en) Combination therapy
GB201706227D0 (en) Combination therapy
GB201706229D0 (en) Combination therapy
GB201706221D0 (en) Combination therapy
GB201706224D0 (en) Combination therapy
GB201706225D0 (en) Combination therapy
GB201706223D0 (en) Combination therapy
GB201706226D0 (en) Combination therapy
GB201706222D0 (en) Combination therapy
GB201706228D0 (en) Combination therapy
GB201704279D0 (en) Combination therapy
GB201704281D0 (en) Combination therapy
GB201704286D0 (en) Combination Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)